Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination Act
Genetic Testing and Molecular Biomarkers · 2019-02 · 23 (2) · 75-83
DOI: 10.1089/gtmb.2018.0253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, online erschienen am 08.02.2019. Verfasst von Deborah Cragun und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Global Health, College of Public Health, University of South Florida, Tampa, Florida. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Aims
This study compared facilitators and barriers to genetic testing and determined awareness about the Genetic Information Nondiscrimination Act (GINA) across young Hispanic and non-Hispanic white (NHW) breast cancer (BC) survivors. Materials and Methods: Women diagnosed with BC of age ≤50 years in 2009-2012 were recruited through the Florida State Cancer Registry to complete a questionnaire.
Results
There were 1182 participants of which 61% (174/285) of Hispanic patients, and 65% (580/897) of NHW patients had BC testing. Among untested participants, the most common barriers were lack of testing recommendation (44% Hispanics, 32% NHW; p = 0.02) and cost-related concerns (41% Hispanics, 40% NHW; p = 0.83). Among tested participants, the top facilitators were as follows: (1) “To benefit my family's future” (70% Hispanic, 68% NHW), (2) “My doctor recommended testing” (60% Hispanic, 54% NHW), and (3) “Minimal cost to me” (59% Hispanic, 72% NHW). Only 27% of tested and 15% of untested women were aware of GINA; misuse of test results was reported as a barrier for only 6.5%.
Conclusions
Rates of genetic testing recommendation are lower among Hispanics, but both groups reported additional barriers. Most are unaware of GINA, yet misuse is not a highly cited barrier. Findings suggest the need to educate providers on the importance of recommending testing to all who meet criteria; increase awareness of newer options for more affordable testing; and bolster facilitators that may increase testing uptake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1 Department of Global Health, College of Public Health, University of South Florida, Tampa, Florida.
- 2 Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.
- 3 Vanderbilt University Medical Center, Department of Medicine, Division of Genetic Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
Förderung
- NCI NIH HHS
Zitieren
APA
Cragun, D., Weidner, A., Kechik, J., & Pal, T. (2019). Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination Act. Genetic Testing and Molecular Biomarkers, 23(2), 75-83. https://doi.org/10.1089/gtmb.2018.0253
Vancouver
Cragun D, Weidner A, Kechik J, Pal T. Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination Act. Genetic Testing and Molecular Biomarkers. 2019;23(2):75-83. doi:10.1089/gtmb.2018.0253
BibTeX
@article{Cragun2019,
author = {Cragun, Deborah and Weidner, Anne and Kechik, Joy and Pal, Tuya},
title = {Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination Act},
journal = {Genetic Testing and Molecular Biomarkers},
year = {2019},
volume = {23},
number = {2},
pages = {75--83},
doi = {10.1089/gtmb.2018.0253}
}
EUVIMED